Results 291 to 300 of about 151,635 (354)

Hot Topics in Implant-Based Breast Reconstruction. [PDF]

J Clin Med
Sorenson TJ, Boyd CJ, Karp NS.
europepmc   +1 more source

Research Progress of Magnesium Alloys and Its Alloys in Medical Applications. [PDF]

Int J Gen Med
Meng X, Liu A, Wu C, Han X, Yang Q, Qiu H, Li X, Cai M, Duan T, Wang Z.   +9 more
europepmc   +1 more source

Transforming Dental Care, Practice and Education with Additive Manufacturing and 3D Printing: Innovations in Materials, Technologies, and Future Pathways. [PDF]

Dent J (Basel)
Monalisa S, Alipuor M, Paul D, Rahman MA, Siddika N, Apu EH, Mostafiz RB.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Implantable Drug Delivery System

International Journal of Multidisciplinary Research and Growth Evaluation
In this paper, we present a shape-programmable magnetically actuated soft capsule robot for semiim plan table drug delivery applications. The shape of the proposed soft capsule is changed by an external magnetic field. To change the robot shape by an external permanent magnet, the relevant soft robot design features and required conditions are ...
S. Upadhyay, S. Soni, T. Shukla, G. Jain, A. Thakar, H. Chaurasiya, Sharad Prakash Pandey   +6 more
  +7 more sources

Drug-implantable cardioverter–defibrillator interactions

Expert Review of Cardiovascular Therapy, 2010
Antiarrhythmic drugs are commonly used synergistically with implantable cardioverter defibrillators in the management of ventricular and supraventricular arrhythmias. However, these drugs may directly or indirectly interact with device function. In addition, expanding indications for implantable cardioverter defibrillators, particularly in patients ...
Roger, Beadle, Lynne, Williams, Hoong Sern, Lim   +2 more
openaire   +2 more sources

Drug-Eluting Medical Implants

2009
Drug-eluting medical implants are actually active implants that induce healing effects, in addition to their regular task of support. This effect is achieved by controlled release of active pharmaceutical ingredients (API) into the surrounding tissue.
Meital, Zilberman, Amir, Kraitzer, Orly, Grinberg, Jonathan J, Elsner   +3 more
openaire   +2 more sources

Drug-Eluting Implants for Osteomyelitis

Critical Reviews™ in Therapeutic Drug Carrier Systems, 2007
Osteomyelitis, an inflammatory process accompanied by bone destruction, is caused by infective microorganisms. The high success rates of antimicrobial therapy by conventional routes of administration in controlling most infectious diseases have not yet been achieved with osteomyelitis for several reasons.
Chidambaram, Soundrapandian, Someswar, Datta, Biswanath, Sa   +2 more
openaire   +2 more sources

Drug delivery from ocular implants

Expert Opinion on Drug Delivery, 2006
Developing an intraocular drug delivery system (DDS) is urgently needed because most vitreoretinal diseases are refractory to conventional pharmacological approaches; eye drops and systemically administered drugs cannot deliver therapeutic drug concentrations into vitreoretinal tissue. Intraocular DDSs address this problem.
Tsutomu, Yasukawa, Yuichiro, Ogura, Hideya, Kimura, Eiji, Sakurai, Yasuhiko, Tabata   +4 more
openaire   +2 more sources